Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financcial Result ....
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 01 Aug 2026, 12:27 PM IST · BSE ID: cc0b5fcd-2ab6-4d10-b51d-c67e163b9e76
View Original BSE Filing (PDF)
💡
In Simple Terms
Rekvina Laboratories' board will meet on August 13, 2026, to review and approve financial results for the quarter ending June 2026.
🤖 AI Summary
- Board meeting scheduled for Rekvina Laboratories Ltd on August 13, 2026.
- Meeting primarily to consider Un-Audited Standalone Financial Results for Quarter ended June 30, 2026.
- Trading window for designated persons closed from July 01, 2026.
- Window remains closed until 48 hours post financial results public disclosure.
- Announcement made under Regulation 29 of SEBI (LODR) Regulations, 2015.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any action based on this intimation of a board meeting.
👤
Who Is Affected
All shareholders are indirectly affected as the upcoming financial results will provide updated performance metrics for Rekvina Laboratories Ltd.
🔍
Management Signal
The management is adhering to regulatory timelines for financial reporting and insider trading regulations by intimating the board meeting and trading window closure.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Rekvina Laboratories Ltd Q1 FY27 financial results release post August 13, 2026.
Any other agenda items approved by the Board on August 13, 2026.
Trading window reopening for designated persons after results disclosure.
LOW RISK
This filing is a routine intimation of a board meeting, presenting no immediate specific risks.
💡 Investor Takeaway
Rekvina Laboratories Ltd's Board of Directors will convene on August 13, 2026, to review and approve the unaudited standalone financial results for the quarter ended June 30, 2026. The trading window for designated persons remains closed from July 01, 2026, until results are publicly disclosed.
❓ Frequently Asked Questions
When is Rekvina Laboratories Ltd's next Board Meeting scheduled?
The Board of Directors of Rekvina Laboratories Ltd is scheduled to meet on August 13, 2026.
What is the primary agenda for Rekvina Laboratories Ltd's Board Meeting on August 13, 2026?
The primary agenda is to consider and approve the Un-Audited Standalone Financial Results for the Quarter ended on 30th June, 2026.
When did the trading window close for Rekvina Laboratories Ltd designated persons?
The trading window for designated persons of Rekvina Laboratories Ltd closed from July 01, 2026.
When will the trading window reopen for Rekvina Laboratories Ltd?
The trading window will remain closed until the expiry of 48 hours from the date the financial results are made public.
Questions based on this BSE filing only. For information purposes.